Type 1 Diabetes Clinical Trials in New York, New York

5 studies are recruiting for type 1 diabetes in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

   This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

   Stage

   Phase 1

   Ages

   12 to 35

   Site

   Hassenfield Children's Hospital, New York, New York

   Locations

   45 in total

   Run by

   COUR Pharmaceutical Development Company, Inc.

   See if you can join NCT06783309 on ClinicalTrials.gov

2. Long-Term Outcomes of Teplizumab in Routine Clinical Care

   This is an observational, prospective cohort study designed to evaluate the outcomes after teplizumab treatment in participants with Stage 2 Type 1 Diabetes (T1D) for delaying the onset of Stage 3 T1D. The study will monitor participants receiving teplizumab as part of routine clinical care across …

   Stage

   Not phased

   Ages

   Any age

   Site

   Investigational Site Number: 8400001, New York, New York

   Locations

   10 in total

   Run by

   Sanofi

   See if you can join NCT07360080 on ClinicalTrials.gov

3. Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

   This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mount Sinai, New York, New York

   Locations

   7 in total

   Run by

   Indiana University

   See if you can join NCT07676565 on ClinicalTrials.gov

4. Cholesterol Lowering and Residual Risk in Diabetes, Type 1

   This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather information and record any developments of the outcomes in question. This study will recruit 125 participa…

   Stage

   Phase 4

   Ages

   18 to 89

   Site

   New York VA Hospital, New York, New York

   Locations

   4 in total

   Run by

   NYU Langone Health

   See if you can join NCT05641753 on ClinicalTrials.gov

5. PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

   This research study is called 'PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The PROMISE Study'. The purpose of this study is to find out more about how exposures during pregnancy, such as having an infection, diet and growth may impact later risk of type 1 diabe…

   Stage

   Not phased

   Ages

   0 to 99

   Site

   Mt Sinai, New York, New York

   Locations

   4 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT06141434 on ClinicalTrials.gov